Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism

Drug Metabolism and Disposition : the Biological Fate of Chemicals
Yvonne Y LauLeslie Z Benet

Abstract

Pharmacokinetic coadministration experiments with atorvastatin (ATV) and rifampicin (RIF) in rats were performed to investigate the potential involvement of hepatic uptake transporters, Oatps (organic anion-transporting polypeptides), during hepatic drug elimination, as an in vivo extension of our recently published cellular and isolated perfused liver studies. ATV was administered orally (10 mg/kg) and intravenously (2 mg/kg) to rats in the absence and presence of a single intravenous dose of RIF (20 mg/kg), and pharmacokinetic parameters were compared between control and RIF-treatment groups. RIF markedly increased the plasma concentrations of ATV and its metabolites when ATV was administered orally. The area under the plasma concentration-time curve (AUC(0-infinity)) for ATV also increased significantly after intravenous dosing of ATV with RIF, but the extent was much less than that observed for oral ATV dosing. Significant increases in plasma levels were observed for both metabolites as well. The 7-fold higher AUC ratio of metabolites to parent drug following oral versus intravenous ATV dosing suggests that ATV undergoes extensive gut metabolism. Both hepatic and intestinal metabolism contribute to the low oral bioavailabil...Continue Reading

References

Aug 1, 1979·Journal of Pharmaceutical Sciences·L Z Benet, R L Galeazzi
Jan 1, 1983·Drug Metabolism Reviews·G R Wilkinson
Jul 1, 1995·Clinical Pharmacology and Therapeutics·D Y GomezL Z Benet
Jul 1, 1993·Pharmaceutical Research·B Davies, T Morris
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·E G SchuetzJ D Schuetz
Aug 8, 1998·Clinical Pharmacology and Therapeutics·T KantolaP J Neuvonen
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·L Z BenetV J Wacher
Jun 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K FattingerB Stieger
Nov 14, 2000·The American Journal of Pathology·M F FrommD Schrenk
Jan 24, 2002·The Journal of Pharmacy and Pharmacology·B M JohnsonC J Porter
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·Carolyn L CumminsLeslie Z Benet
Oct 9, 2003·Clinical Pharmacokinetics·Hans Lennernäs
Oct 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·Carolyn L CumminsLeslie Z Benet
Oct 23, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Chi-Yuan Wu, Leslie Z Benet
Nov 25, 2003·The Journal of Pharmacology and Experimental Therapeutics·Yvonne Y LauLeslie Z Benet
Oct 23, 2004·Pharmaceutical Research·Jerome H HochmanThomayant Prueksaritanont
Dec 24, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Cuiping ChenTeresa A Smolarek
Sep 24, 2005·Basic & Clinical Pharmacology & Toxicology·Lauri I KajosaariJanne T Backman
Nov 1, 2005·The Journal of Pharmacology and Experimental Therapeutics·Yvonne Y LauLeslie Z Benet

❮ Previous
Next ❯

Citations

Nov 30, 2010·Journal of Pharmacokinetics and Pharmacodynamics·Leslie Z Benet
Oct 21, 2011·Pharmaceutical Research·Ken-ichi Umehara, Gian Camenisch
Jun 21, 2012·European Journal of Drug Metabolism and Pharmacokinetics·Mahmud KajbafStefano Fontana
Sep 13, 2011·Epilepsia·Vinícius Rafael FunckMauro Schneider Oliveira
Sep 27, 2008·Acta Pharmacologica Sinica·Jing DongGuang-ji Wang
Aug 6, 2011·The AAPS Journal·Leslie Z BenetTudor I Oprea
Dec 19, 2013·European Journal of Drug Metabolism and Pharmacokinetics·Hassan MalekinejadAmir Amniattalab
Oct 2, 2014·Wiener medizinische Wochenschrift·Michaela BöhmdorferWalter Jäger
Oct 29, 2013·Drug Development and Industrial Pharmacy·P A SonarS L Harer
Oct 31, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·P J H WebbornR J Riley
Apr 9, 2013·Toxicology and Applied Pharmacology·Lucy C J EllisRichard J Weaver
Apr 21, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yi-Jing HeHong-Hao Zhou
Sep 1, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·György LengyelKatalin Jemnitz
Oct 13, 2012·The Journal of Pharmacy and Pharmacology·Rahul VatsAditya Narasimha Murthy
Oct 27, 2010·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Anshika SrivastavaBalraj Mittal
Dec 17, 2009·Basic & Clinical Pharmacology & Toxicology·Leslie Z Benet
Nov 29, 2013·Biopharmaceutics & Drug Disposition·Min-Koo ChoiIm-Sook Song
Jul 4, 2012·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Insoo YoonDae-Duk Kim
Dec 23, 2014·Future Medicinal Chemistry·Peter W FanS Cyrus Khojasteh
Jul 20, 2016·Journal of Advanced Pharmaceutical Technology & Research·M M R Meor Mohd AffandiA B A Majeed
Jan 26, 2007·Clinical Pharmacology and Therapeutics·P L M van GiersbergenJ Dingemanse
Dec 29, 2006·Clinical Pharmacology and Therapeutics·Y Y LauL Z Benet
Oct 21, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Masashi UchidaRyoji Hayashi
Nov 2, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Waleed Elsayed Ahmed EllawattyYukio Kato
Mar 29, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jae H ChangJonathan Cheong
Apr 23, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Stuart W PaineRobert J Riley
Jun 17, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Cuiping ChenSonia M de Morais
Mar 23, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kazuya TakeuchiYukio Kato
Jun 4, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Rune AmundsenAnders Asberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Drug Metabolism and Disposition : the Biological Fate of Chemicals
Cuiping ChenTeresa A Smolarek
Drug Metabolism and Disposition : the Biological Fate of Chemicals
Masaru HiranoYuichi Sugiyama
© 2022 Meta ULC. All rights reserved